March 13, 2020 / 11:15 AM / 25 days ago

BRIEF-Lattice Biologics To Evaluate Anti-Inflammatory Stem Cell Therapy Treatment Of Covid-19 Lung Disease

March 13 (Reuters) - Lattice Biologics Ltd:

* LATTICE BIOLOGICS TO EVALUATE ANTI-INFLAMMATORY STEM CELL THERAPY TREATMENT OF COVID-19 LUNG DISEASE

* LATTICE BIOLOGICS - TO EVALUATE AMNIOTIC FLUID CONCENTRATE, AMNIOBOOST, IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME CAUSED BY CORONAVIRUS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below